Skip to main content
Fig. 3 | Hereditas

Fig. 3

From: Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy

Fig. 3

The mRNA expression of has-miR-542-5p target genes and overall survival value. The mRNA expression of has-miR-542-5p target genes including Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) associated with overall survival in breast cancer. The left panel (YWHAB a, LY9 c, SFRP1 e) were verified in Gene Expression Profiling Interactive Analysis (GEPIA) database Red: high expression; blue: low expression; and the right panel (YWHAB b, LY9 d, SFRP1 f) results comes from KMPD. Red: high expression; black: low expression

Back to article page